1、 THIS REPORT CONTAINS ASSESSMENTS OF COMMODITY AND TRADE ISSUES MADE BY USDA STAFF AND NOT NECESSARILY STATEMENTS OF OFFICIAL U.S.GOVERNMENT POLICY Required Report:Required-Public Distribution Date:December 27,2024 Report Number:FR2024-0004 Report Name:Agricultural Biotechnology Annual Country:Franc

2、e Post:Paris Report Category:Biotechnology and Other New Production Technologies Prepared By:Alexandra Robu Approved By:David Leishman Report Highlights:Frances agricultural biotechnology sector is constrained by strict regulations and public opposition,despite the scientific communitys support and

3、the growing interest in NBTs.The dialogue on agricultural innovation and food security is evolving,driven by climate change and geopolitical factors,but significant challenges remain.France,a significant hub for medical biotechnology in Europe,faces stringent regulations,minimal research and develop

4、ment,and low public support for agricultural biotechnology.While the French government permits the import of genetically engineered(GE)products for animal feed,it restricts research and bans cultivation.This situation is unlikely to change in the short term.2 Executive Summary France currently has n

5、o commercial production or field trials of genetically engineered(GE)crops,with the last authorized GE field trial occurring in 2013.Research in agricultural biotechnology is minimal,offering no immediate prospects for commercialization.The French livestock sector heavily depends on imported GE feed

6、,particularly soybeans,rapeseed,and corn sourced from South America,the United States,Canada,and Australia.Despite support from the scientific community and many farmers,consumer attitudes towards new technology remain predominantly negative.Anti-biotechnology groups have been known to destroy suspe